We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFA
1201
MFA Financial
MFA
$935M
$215K 0.01%
6,956
+98
+1% +$2.95K
NDAQ icon
1202
Nasdaq
NDAQ
$53.2B
$215K 0.01%
17,478
-1,767
-9% -$22.8K
GDP
1203
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$215K 0.01%
+13,539
New +$210K
ERC
1204
Allspring Multi-Sector Income Fund
ERC
$254M
$214K 0.01%
14,768
-176
-1% -$2.53K
FLOT icon
1205
iShares Floating Rate Bond ETF
FLOT
$10.2B
$214K 0.01%
+4,228
New +$214K
RWX icon
1206
State Street SPDR Dow Jones International Real Estate ETF
RWX
$273M
$214K 0.01%
+5,191
New +$211K
SBS icon
1207
Sabesp
SBS
$19.2B
$214K 0.01%
119,007
-7,024
-6% -$12.8K
TEX icon
1208
Terex
TEX
$7.11B
$213K 0.01%
4,800
-1,600
-25% -$67.2K
ARRY
1209
DELISTED
Array Biopharma Inc
ARRY
$213K 0.01%
45,400
DRH icon
1210
Diamondrock Hospitality Co
DRH
$2.64B
$212K 0.01%
+18,000
New +$215K
RDY icon
1211
Dr. Reddy's Laboratories
RDY
$9.85B
$212K 0.01%
+24,175
New +$210K
BBY icon
1212
Best Buy
BBY
$18.5B
$210K 0.01%
7,937
-1,160
-13% -$31.8K
BIV icon
1213
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$210K 0.01%
+2,520
New +$210K
DY icon
1214
Dycom Industries
DY
$12.5B
$210K 0.01%
+6,633
New +$190K
OXSQ icon
1215
Oxford Square Capital
OXSQ
$151M
$210K 0.01%
21,560
+8,500
+65% +$86.9K
STWD icon
1216
Starwood Property Trust
STWD
$6.02B
$210K 0.01%
+8,901
New +$211K
VTA
1217
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$210K 0.01%
16,189
-1,500
-8% -$19.4K
SUNE
1218
DELISTED
SUNEDISON, INC COM
SUNE
$210K 0.01%
11,150
-9,701
-47% -$162K
FRA icon
1219
BlackRock Floating Rate Income Strategies Fund
FRA
$383M
$209K 0.01%
14,333
+2,500
+21% +$36.6K
ARQL
1220
DELISTED
Arqule Inc
ARQL
$209K 0.01%
102,050
+10,250
+11% +$23K
NTGR icon
1221
NETGEAR
NTGR
$616M
$208K 0.01%
+6,175
New +$207K
JTP
1222
DELISTED
NUVEEN QUALITY PFD INCOME FD
JTP
$208K 0.01%
25,775
-2,829
-10% -$22.4K
BTZ icon
1223
BlackRock Credit Allocation Income Trust
BTZ
$935M
$207K 0.01%
15,298
+718
+5% +$9.5K
OEF icon
1224
iShares S&P 100 ETF
OEF
$19.9B
$207K 0.01%
+2,500
New +$203K
CHW
1225
Calamos Global Dynamic Income Fund
CHW
$523M
$206K 0.01%
22,813
+1,847
+9% +$16.6K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.